User profiles for Flavia Riccardo

Flavia Riccardo

MD, PhD
Verified email at iss.it
Cited by 5166

[HTML][HTML] First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

…, M Valette, B Lina, F Riccardo… - …, 2020 - eurosurveillance.org
In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020.
We detail the first European cases. As at 21 February, nine European countries reported 47 …

[HTML][HTML] Characteristics of SARS-CoV-2 variants of concern B. 1.1. 7, B. 1.351 or P. 1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

…, T Abdelrahman, F Riccardo… - …, 2021 - eurosurveillance.org
We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436
B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-…

[HTML][HTML] Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020

F Riccardo, M Ajelli, XD Andrianou, A Bella… - …, 2020 - eurosurveillance.org
Background On 20 February 2020, a locally acquired coronavirus disease (COVID-19) case
was detected in Lombardy, Italy. This was the first signal of ongoing transmission of severe …

COVID-19 disease severity risk factors for pediatric patients in Italy

…, M Fabiani, S Boros, F Vescio, F Riccardo… - …, 2020 - publications.aap.org
OBJECTIVES: To describe the epidemiological and clinical characteristics of coronavirus
disease (COVID-19) pediatric patients aged< 18 years in Italy. METHODS: Data from the …

[HTML][HTML] Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 …

…, R Nikiforova, F Riccardo… - …, 2021 - eurosurveillance.org
Since December 2019, over 1.5 million SARS-CoV-2-related fatalities have been recorded
in the World Health Organization European Region - 90.2% in people ≥ 60 years. We …

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January …

…, A Mateo-Urdiales, MC Rota, D Petrone, F Riccardo… - The Lancet, 2022 - thelancet.com
Background By April 13, 2022, more than 4 months after the approval of BNT162b2 (Pfizer–BioNTech)
for children, less than 40% of 5–11-year-olds in Italy had been vaccinated against …

Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy

…, V Raparelli, P Pezzotti, F Riccardo… - The Journals of …, 2020 - academic.oup.com
Background Aim of the present study is to describe characteristics of COVID-19-related deaths
and to compare the clinical phenotype and course of COVID-19-related deaths occurring …

Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in …

…, A Filia, F D'Ancona, M Del Manso, F Riccardo… - Bmj, 2022 - bmj.com
Objectives To estimate the effectiveness of mRNA vaccines against SARS-CoV-2 infection
and severe covid-19 at different time after vaccination. Design Retrospective cohort study. …

[HTML][HTML] Temporal dynamics in total excess mortality and COVID-19 deaths in Italian cities

…, M De Sario, G Costa, F Noccioli, F Riccardo… - BMC public health, 2020 - Springer
Background Standardized mortality surveillance data, capable of detecting variations in total
mortality at population level and not only among the infected, provide an unbiased insight …

[HTML][HTML] Detection of a chikungunya outbreak in Central Italy, August to September 2017

…, C Fortuna, ME Remoli, F Riccardo… - …, 2017 - eurosurveillance.org
An autochthonous chikungunya outbreak is ongoing near Anzio, a coastal town in the province
of Rome. The virus isolated from one patient and mosquitoes lacks the A226V mutation …